http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2285042-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2cffd15bc78c2ba98affaac1d048befb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K2-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-21 |
| filingDate | 2001-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73222ed8f1e0908ae6414d4ac4024cad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbc2941c7a8ca2eb00eb15c4d6dfb501 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b959771a8eacfcf7fe09576b5374009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c365765e4accbf19c7111f8000cfff75 |
| publicationDate | 2006-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2285042-C2 |
| titleOfInvention | New mutant allergens |
| abstract | FIELD: biotechnology, medicine. n SUBSTANCE: invention relates to new recombinant allergens that represent mutants of allergens of the natural origin and comprising at least four mutations. Examples of recombinant allergens are allergens Bet v1 and Ves v1. The primary mutations in recombinant allergen are separated of one another by interval for at least 15 Å and is location is characterized by that at least one circle region of surface of size 800 Å doesn't comprise mutations. Recombinant allergens are used as a pharmaceutical agent as a component of pharmaceutical composition that represents vaccine against allergic response reactions. Invention describes methods for using recombinant allergens in pharmaceutical composition for producing the immune response in subject. Invention represents DNA sequences given in the invention claim that encode recombinant allergens, expressing vector comprising DNA and cell-host for providing the recombinant allergen. Also, invention describes methods for preparing pharmaceutical composition and recombinant mutant allergen. Using recombinant allergen allows decreasing the specific IgE-binding capacity as compared with IgE-binding capacity of the natural allergen. Invention can be used in medicine for preparing vaccine against allergic response reactions. n EFFECT: valuable medicinal properties of allergens. n 33 cl, 62 dwg, 10 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11266737-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2630652-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11096994-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2608494-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2687164-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2618840-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2592674-C2 |
| priorityDate | 2000-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 269.